Toronto: An inhaled form of COVID-19 vaccine developed by scientists at McMaster University in Canada can provide broad, long-lasting protection against the SARS-CoV-2 variants of concern, a preclinical study has found. The research, published recently in the journal Cell, shows the immune mechanisms and significant benefits of vaccines being delivered directly into the respiratory tract, rather […]
